Cargando…
Mechanism of selenomethionine inhibiting of PDCoV replication in LLC-PK1 cells based on STAT3/miR-125b-5p-1/HK2 signaling
There are no licensed therapeutics or vaccines available against porcine delta coronavirus (PDCoV) to eliminate its potential for congenital disease. In the absence of effective treatments, it has led to significant economic losses in the swine industry worldwide. Similar to the current coronavirus...
Autores principales: | Ren, Zhihua, Ding, Ting, He, Hongyi, Wei, Zhanyong, Shi, Riyi, Deng, Junliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436478/ https://www.ncbi.nlm.nih.gov/pubmed/36059492 http://dx.doi.org/10.3389/fimmu.2022.952852 |
Ejemplares similares
-
Prediction and Verification of Curcumin as a Potential Drug for Inhibition of PDCoV Replication in LLC-PK1 Cells
por: Wang, Xuefei, et al.
Publicado: (2023) -
Exploration of PDCoV-induced apoptosis through mitochondrial dynamics imbalance and the antagonistic effect of SeNPs
por: Ren, Zhihua, et al.
Publicado: (2022) -
Phylogenetic Classification of Global Porcine Deltacoronavirus (PDCoV) Reference Strains and Molecular Characterization of PDCoV in Taiwan
por: Hsueh, Fu-Chun, et al.
Publicado: (2021) -
Porcine Deltacoronavirus (PDCoV) Entry into PK-15 Cells by Caveolae-Mediated Endocytosis
por: Li, Shiqian, et al.
Publicado: (2022) -
Tandem Mass Tag-Based Quantitative Proteome Analysis
of Porcine Deltacoronavirus (PDCoV)-Infected LLC Porcine Kidney Cells
por: Gao, Xiang, et al.
Publicado: (2020)